Literature DB >> 19828488

Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme.

Mona Loutfy1, Esteban Ribera, Eric Florence, Stéphane De Wit, Antonella Castagna, Robert Ryan, Andrew Hill, Hilde Vanaken, Yvonne van Delft, Stephan Marks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19828488     DOI： 10.1093/jac/dkp366

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  2 in total

Review 1.  Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results.

Authors:  Babafemi Taiwo; Robert L Murphy; Christine Katlama
Journal:  Drugs       Date:  2010-09-10       Impact factor: 9.546

2.  Profile of etravirine for the treatment of HIV infection.

Authors:  Alice Tseng; Rodger D Macarthur
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.